Low Volatility Means Low Turnover?
Nov 29, 2017
Jeremy Parkinson
Finance
ZeroHedge had an interesting article about the very low turnover in hedge funds in the third quarter, only 26%. The title of the article includes the word paralyzed but the text rules out complacency. Instead, the conclusion seems to be that the market is going up in a way that just should not be, summed up as […]
November 2017 Beige Book: Reading Between The Lines – Rate Of Economic Expansion Unchanged
Nov 29, 2017
Jeremy Parkinson
Finance
The consolidated economic report from the 12 Federal Reserve Districts (Beige Book) stated “activity continued to increase at a modest to moderate pace in October and mid-November“. The previous report stated “activity increased in September through early October, with the pace of growth split between modest and moderate”. Analyst Opinion of this month’s Beige Book […]
Carnage: Wednesday’s Tech Bloodbath In Pictures
Nov 29, 2017
Jeremy Parkinson
Finance
Boy, I’ve got to tell you, Wednesday is shaping up to be an absolute train wreck for FANG, for the Nasdaq, and for everyone’s favorite crowded trades more generally. Specifically, the Nasdaq 100 is having its worst day since August 17, when rumors that Gary Cohn was set to resign following Trump’s Charlottesville presser […]
Give Auto Parts A Try?
Nov 29, 2017
Jeremy Parkinson
Finance
In spite of what you’ve heard, shorting stocks in 2017 has not been like shooting yourself in the foot. Don’t believe it. Because at least when you shoot yourself in the foot, it causes some excitement and, later, sympathy. In spite of this, for those foolish enough to give it another whirl, the two big auto parts […]
The UK Was The Best Part Of The European Union
Nov 29, 2017
Jeremy Parkinson
Finance
In the debate around the Brexit referendum in the United Kingdom, the side arguing on behalf of Britain remaining a part of the EU wasn’t a particularly convincing one. Positions for “Remain” were largely based on emotions. There is, however, one very convincing point for a British remainder in the union. The Rebel Voice Since […]
Gold Being Odd And USD Being Tricky
Nov 29, 2017
Jeremy Parkinson
Finance
Every now and then we see some kind of anomaly on the precious metals market. Sometimes it’s particularly useful and sometimes it’s just something random. Yesterday was one of those days when something didn’t seem right. The USD Index rallied, silver declined, mining stocks declined and yet, gold closed the session higher. What can we […]
JP Morgan: 5 Top Stocks For The AI Explosion
Nov 29, 2017
Jeremy Parkinson
Finance
JP Morgan’s research team has just published an investor report revealing its top AI stock picks, shows CNBC. These are 5 of the firm’s ‘buy-rated’ stocks that should profit from the huge growth in AI. “We are at a pivotal point for its adoption today due to the availability of big data, high-powered computing and […]
Third-Quarter GDP Hits Consensus 3.3% Estimate
Nov 29, 2017
Jeremy Parkinson
Finance
The BEA reported the second estimate of third-quarter GDP was 3.3%. The report matched the Econoday consensus. Real gross domestic product (GDP) increased at an annual rate of 3.3% in the third quarter of 2017 according to the “second” estimate released by the Bureau of Economic Analysis. Real gross domestic income (GDI) increased 2.5% in the third […]
Regal Entertainment Group Shares Halt Then Catch A Buyout Offer After-Hours
Nov 29, 2017
Jeremy Parkinson
Finance
Regal Entertainment Group (NYSE: RGC) For the majority of Americans, you can pretty much bet that they have been in a building that is owned and operated by Regal Entertainment Group. You see, this is one of the largest cinema production companies in the world and in the US. They operate movie theaters in 42 […]
Cesca Therapeutics Inc. Announces Pricing Of Public Offering Of Up To 900,000 Shares Of Common Stock
Nov 29, 2017
Jeremy Parkinson
Finance
RANCHO CORDOVA, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) — Cesca Therapeutics Inc. (“Cesca”) (Nasdaq:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that it has priced a best efforts registered public offering of up to an aggregate of 900,000 shares of the Company’s common stock at a price to […]